Disease & disorder
acromegaly
MONDO:0019933
Acromegaly is an acquired disorder related to excessive production of growth hormone (GH) and characterized by progressive somatic disfigurement (mainly involving the face and extremities) and systemic manifestations.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
9 shownNeuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical ModelsNCT06326853 · 2024-07-01
NOT_YET_RECRUITINGVitamin D Metabolism in Patients With Endocrine DisordersNCT04844164 · 2019-04-16
COMPLETEDSeoul National University Pituitary Disease Cohort StudyNCT03474601 · 2015-03-15
UNKNOWNStudy to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesNCT01794793 · 2013-06-10
COMPLETEDPeripheral Metabolic Effects of SomatostatinNCT01062529 · 2009-10-01
COMPLETEDGrowth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)NCT00915954 · 2008-12-01
COMPLETEDGlucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin ResistanceNCT00663000 · 2008-04-01
COMPLETEDPhysiopathology of Sodium Retention in AcromegalyNCT00531908 · 2007-09-01
COMPLETEDChanges of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist PegvisomantNCT00552851 · 2006-06-01
UNKNOWNDrugs being studied
Research locations
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.